Literature DB >> 35273009

Drug-Induced Acute Kidney Injury.

Mark A Perazella1,2, Mitchell H Rosner3.   

Abstract

Medications are a common cause of AKI, especially for patients admitted to hospital wards and the intensive care unit. Although drug-related kidney injury occurs through different mechanisms, this review will focus on three specific types of tubulointerstitial injury. Direct acute tubular injury develops from several medications, which are toxic to various cellular functions. Their excretory pathways through the proximal tubules contribute further to AKI. Drug-induced AKI may also develop through induction of inflammation within the tubulointerstitium. Medications can elicit a T cell-mediated immune response that promotes the development of acute interstitial nephritis leading to AKI. Although less common, a third pathway to kidney injury results from the insolubility of drugs in the urine leading to their precipitation as crystals within distal tubular lumens, causing a crystalline-related AKI. Intratubular obstruction, direct tubular injury, and localized inflammation lead to AKI. Clinicians should be familiar with the pathogenesis and clinical-pathologic manifestations of these forms of kidney injury. Prevention and treatment of AKI relies on understanding the pathogenesis and judiciously using these agents in settings where AKI risk is high.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  Critical Care Nephrology and Acute Kidney Injury Series; acute interstitial nephritis; acute kidney injury; acute tubular injury; apoptosis; chronic kidney disease; crystalline nephropathy; drugs; inflammation; nephrotoxins

Mesh:

Year:  2022        PMID: 35273009      PMCID: PMC9435983          DOI: 10.2215/CJN.11290821

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  118 in total

1.  Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?

Authors:  Hassane Izzedine; Vincent Thibault; Marc Antoine Valantin; Gilles Peytavin; Luminita Schneider; Yves Benhamou
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

2.  Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis.

Authors:  Gema Fernandez-Juarez; Javier Villacorta Perez; Fernando Caravaca-Fontán; Luis Quintana; Amir Shabaka; Eva Rodriguez; Liliana Gadola; Alberto de Lorenzo; Maria Angeles Cobo; Aniana Oliet; Milagros Sierra; Carmen Cobelo; Elena Iglesias; Miguel Blasco; Cristina Galeano; Alfredo Cordon; Jesus Oliva; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-05       Impact factor: 8.237

Review 3.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

4.  Proton Pump Inhibitors and CKD.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

Review 5.  New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

Authors:  Jose M Lopez-Novoa; Yaremi Quiros; Laura Vicente; Ana I Morales; Francisco J Lopez-Hernandez
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

6.  Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.

Authors:  R L Schilsky; T Anderson
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

7.  Renal dysfunction during and after high-dose methotrexate.

Authors:  Myke R Green; Marc C Chamberlain
Journal:  Cancer Chemother Pharmacol       Date:  2008-05-27       Impact factor: 3.333

8.  A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Meghan N Jeffres; Warren Isakow; Joshua A Doherty; Scott T Micek; Marin H Kollef
Journal:  Clin Ther       Date:  2007-06       Impact factor: 3.393

Review 9.  The Nephrotoxicity of Vancomycin.

Authors:  E J Filippone; W K Kraft; J L Farber
Journal:  Clin Pharmacol Ther       Date:  2017-06-05       Impact factor: 6.875

10.  Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis.

Authors:  Dennis G Moledina; F Perry Wilson; Lidiya Kukova; Wassim Obeid; Randy Luciano; Michael Kuperman; Gilbert W Moeckel; Michael Kashgarian; Mark A Perazella; Lloyd G Cantley; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2021-09-27       Impact factor: 5.992

View more
  4 in total

1.  Acute Interstitial Nephritis following Lenalidomide Therapy in a Patient with AL Amyloidosis.

Authors:  Urmila Anandh; Bharat Vaswani; Swarnalata Gowrishankar
Journal:  Indian J Nephrol       Date:  2022-07-16

2.  The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study.

Authors:  Ruiqiu Zhang; Yanxin Liu; Jia Cao; Jiahui Lao; Baobao Wang; Siwen Li; Xin Huang; Fang Tang; Xiao Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

3.  A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium-Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study.

Authors:  Ioana Frent; Daniel Leucuta; Camelia Bucsa; Andreea Farcas; Florin Casoinic; Cristina Mogosan
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

4.  Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.

Authors:  Elizabeth E Roughead; Mhairi Kerr; Anna Moffat; Gizat M Kassie; Nicole Pratt
Journal:  Drug Saf       Date:  2022-09-21       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.